According to Drucker the findings, published in December 2023, provided the first demonstration of 'a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors.' Drucker's team has not yet identified which particular brain cells interact with GLP-1 (AAAS)
In terms of anticancer effects, ZnO nanoparticles are sensitive to blood tumor cells, producing ROS to induce apoptosis, and have less impact on normal cells
Side Effects Some people notice mild side effects while using Zepboundespecially during the early stages of treatment
AOD 9604 is sometimes discussed for patients who do not tolerate GLP-1 medications, a decision best made with a provider
However, as GLP-1R expression is generally absent in most tumor specimens, the anticancer effects of Ex-4 may be restricted to specific patients with ovarian cancer who also have diabetes [72]
Find more on Interview Query